The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis

Molecular Immunology

Volumn 58, Issue 1, 2014, Pages 85-91

  Ju, Ying ^a   Shang, Xuming ^a   Liu, Zhanfeng ^a   Zhang, Ji ^a   Li, Yuantang ^a   Shen, Yajuan ^a   Liu, Yiqing ^a   Liu, Chunmei ^a   Liu, Bin ^a   Xu, Liyun ^b   Wang, Yong ^a   Zhang, Bingchang ^a   Zou, Jianwen ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Zhoushan Hospital   (China)

Author keywords

Concanavalin A; Effector T cells; Homeostasis; Regulatory T cells; T cell immunoglobulin and mucin domain containing molecule 3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD4 ANTIGEN; CONCANAVALIN A; ECALECTIN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; KIDNEY INJURY MOLECULE 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEPATITIS; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER INJURY; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION;

ACUTE GRAFT-VERSUS-HOST DISEASE; AGVHD; ALANINE AMINOTRANSFERASE; ALT; ASPARTATE TRANSAMINASE; AST; CON A; CONCANAVALIN A; EFFECTOR T CELLS; HBV; HEPATIC MONONUCLEAR CELLS; HEPATITIS B VIRUS; HMCS; HOMEOSTASIS; IFN-Γ; IL-10; IL-2; INTERFERON-Γ; INTERLEUKIN 10; INTERLEUKIN 2; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; QPCR; QUANTITATIVE REAL-TIME PCR; REGULATORY T CELLS; T CELL IMMUNOGLOBULIN- AND MUCIN-DOMAIN-CONTAINING MOLECULE-3; T CELL RECEPTOR; TCR; TEFFS; TGF-Β; TIM-3; TNF-Α; TRANSFORMING GROWTH FACTOR; TREGS; TUMOR NECROSIS FACTOR-Α;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD4; APOPTOSIS; CONCANAVALIN A; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; HEPATITIS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, VIRUS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84890065399     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.11.001     Document Type: Article

References (33)

1. Anderson A.C., Anderson D.E. TIM-3 in autoimmunity. Curr. Opin. Immunol. 2006, 18:665-669.
2. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T.C., Cumano A., Bandeira A. CD4+ CD25+ T cells regulate the expansion of CD4 T cells through the production of IL-10. J. Immunol. 2001, 166:3008-3018.
3. Boenisch O., D'Addio F., Watanabe T., et al. TIM-3: a novel regulatory molecule of alloimmune activation. J. Immunol. 2010, 185:5806-5819.
4. Bowen D.G., McCaughan G.W., Bertolino P. Intrahepatic immunity: a tale of two sites?. Trends Immunol. 2005, 26:512-517.
5. Crispe I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 2003, 3:51-62.
6. Dong Z., Zhang J., Sun R., Wei H., Tian Z. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007, 45:1400-1412.
7. Erhardt A., Biburger M., Papadopoulos T., Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007, 45:475-485.
8. Gantner F., Leist M., Lohse A.W., Germann P., Tiegs G. Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995, 21:190-198.
9. Gao X., Zhu Y., Li G., Huang H., Zhang G., Wang F., et al. TIM-3 expression characterizes regulatory t cells in tumor tissues and is associated with lung cancer progression. PLoS ONE 2012, 7:e30676.
10. Hafler D.A., Kuchroo V. TIMs: central regulators of immune responses. J. Exp. Med. 2008, 205:2699-2701.
11. Ju Y., Hou N., Zhang X.N., et al. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection. Cell. Mol. Immunol. 2009, 6:35-43.
12. Kageshita T., Kashio Y., Yamauchi A., et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int. J. Cancer 2002, 99:809-816.
13. Kashio Y., Nakamura K., Abedin M.J., et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 2003, 170:3631-3636.
14. Kaufmann T., Jost P.J., Pellegrini M., et al. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 2009, 30:56-66.
15. Kennedy P.T., Sandalova E., Jo J., et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 2012, 143:637-645.
16. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., Strober W. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 2003, 198:1179-1188.
17. K̈sters S., Gantner F., K̈nstle G., Tiegs G. Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-471.
18. Lee J., Oh J.M., Hwang J.W., Ahn J.K., Bae E.K., Won J., Koh E.M., Cha H.S. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis. Scand. J. Rheumatol. 2011, 40:334-340.
19. Li H., Wu K., Tao K., et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012, 56:1342-1351.
20. Lv K., Zhang Y., Zhang M., Zhong M., Suo Q. Galectin-9 ameliorates Con A-induced hepatitis by inducing CD4(+)CD25(low/int) effector T-cell apoptosis and increasing regulatory T cell number. PLoS ONE 2012, 7:e48379.
21. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine dependent mechanisms. J. Exp. Med. 2003, 197:111-119.
22. Matsumoto R., Matsumoto H., Seki M., et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 1998, 273:16976-16984.
23. Monney L., Sabatos C.A., Gaglia J.L., et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415:536-541.
24. Moorman J.P., Wang J.M., Zhang Y., et al. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J. Immunol. 2012, 189:755-766.
25. Oikawa T., Kamimura Y., Akiba H., et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J. Immunol. 2006, 177:4281-4287.
26. Sabatos C.A., Chakravarti S., Cha E., et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 2003, 4:1102-1110.
27. Saita N., Goto E., Yamamoto T., et al. Association of galectin-9 with eosinophil apoptosis. Int. Arch. Allergy Immunol. 2002, 128:42-50.
28. Seki M., Oomizu S., Sakata K.M., et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
29. Tiegs G., Hentschel J., Wendel A. A T-cell dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992, 90:196-203.
30. Toda A., Piccirillo C.A. Development and function of naturally occurring CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 2006, 80:458-470.
31. Wada J., Ota K., Kumar A., Wallner E.I., Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a b-galactoside binding lectin. J. Clin. Invest. 1997, 99:2452-2461.
32. Wang F., Wan L., Zhang C., Zheng X., Li J., Chen Z.K. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology 2009, 214:342-349.
33. Zhu C., Anderson A.C., Schubart A., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.